CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis
Prescription ω-3 fatty acid ethyl ester supplements are commonly used for the treatment of hypertriglyceridemia. However, the metabolic profile and effect of the metabolites formed by these treatments remain unknown. Here we utilized unbiased metabolomics to identify 3-carboxy-4-methyl-5-propyl-2-fu...
Main Authors: | Kacey J. Prentice, Stacy G. Wendell, Ying Liu, Judith A. Eversley, Sonia R. Salvatore, Haneesha Mohan, Sydney L. Brandt, Andrew C. Adams, X. Serena Wang, David Wei, Garret A. FitzGerald, Timothy B. Durham, Craig D. Hammond, Kyle W. Sloop, Carsten Skarke, Francisco J. Schopfer, Michael B. Wheeler |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396417305017 |
Similar Items
-
Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development
by: Ying Liu, et al.
Published: (2016-03-01) -
CMPF: Class-switching minimized pathfinding in metabolic networks
by: Lim Kevin, et al.
Published: (2012-12-01) -
CMPF does not associate with impaired glucose metabolism in individuals with features of metabolic syndrome.
by: Maria A Lankinen, et al.
Published: (2015-01-01) -
The State of the Catholic Church in Ireland at the Start of the 21st Century
by: FitzGerald, Garret -
Early overnutrition in male mice negates metabolic benefits of a diet high in monounsaturated and omega-3 fats
by: Maria M. Glavas, et al.
Published: (2021-07-01)